湖北“肺炎1号”方治疗新型冠状病毒肺炎的肠道微生态机制探讨  

Mechanism of Hubei“Pneumonia No.1”decoction for treatment of COVID-19 n with regard to intestinal microecology

作　　者：袁榛 舒兰[1] 谭周进[2] Zhen Yuan;Lan Shu;Zhou-Jin Tan(Department of Pediatrics,The First Affiliated Hospital of Hunan University of Chinese Medicine,Changsha 410007,Hunan Province,China;Department of Microbiology,Hunan University of Chinese Medicine,Changsha 410208,Hunan Province,China)

机构地区：[1]湖南中医药大学第一附属医院儿科,湖南省长沙市410007 [2]湖南中医药大学微生物学教研室,湖南省长沙市410208

出　　处：《世界华人消化杂志》2021年第3期105-109,共5页World Chinese Journal of Digestology

摘　　要：国内新型冠状病毒肺炎(新冠肺炎)疫情的有效防治离不开中医药的积极参与.湖北省中医院创立的“肺炎1号”方,是以小柴胡汤合达原饮加减为基本方,并结合当地新冠肺炎患者的证候特点而成.本文分析探讨了新型冠状病毒肺炎与肠道微生态之间的关联,并从中医理论与肠道微生态理论的一致性角度入手,探究“肺炎1号”通过肠道微生态治疗新型冠状病毒肺炎的可能作用机制,为中医药治疗新冠肺炎的临床效用提供理论支撑.Chinese medicine plays an important role in the prevention and control of corona virus disease 2019(COVID-19)epidemic.Based on the symptoms and signs of COVID-19,using the modified Xiaochaihu Decoction Decoction as the basic and based on the symptoms and signs of COVID-19,Hubei Provincial Traditional Chinese Medical Hospital developed the“Pneumonia No.1”decoction for the treatment of COVID-19.In this paper,we discuss the relationship between COVID-19 and intestinal microflora,and explore the possible mechanism of“Pneumonia No.1”decoction for treatment of COVID-19 from the perspective of intestinal microflora,with an aim to provide theoretical support for the clinical efficacy of Chinese medicine in treating COVID-19.

关 键 词：新型冠状病毒肺炎(新冠肺炎) 肠道微生态 中医药 

分 类 号：R259[医药卫生—中西医结合]